Mustang Bio (MBIO) Retained Earnings (2016 - 2026)
Mustang Bio (MBIO) posted quarterly Retained Earnings of -$399.6 million for Q1 2026, down 0.68% year-over-year from -$402.3 million in Q1 2025, and little changed quarter-over-quarter from -$398.6 million in Q4 2025.
Mustang Bio (MBIO) Retained Earnings (2016 - 2026) Analysis & Trends
Mustang Bio (MBIO) has reported Retained Earnings for 11 consecutive years, with -$399.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 0.68% year-over-year to -$399.6 million; the TTM figure through Mar 2026 stood at -$399.6 million (down 0.68% YoY), while the FY2025 annual figure was -$398.6 million, changed 0.48% from the prior year.
- Retained Earnings steadied at -$399.6 million in Q1 2026 per MBIO's latest filing, from -$398.6 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$271.6 million in Q1 2022 and bottomed at -$399.6 million in Q1 2026.
- Historically, Retained Earnings has averaged -$366.3 million across 5 years, with a median of -$386.2 million in 2024.
- Annual changes were most pronounced in 2022 — Retained Earnings plunged 35.53% — and 2025, when it slipped 0.48%.
- Mustang Bio's Retained Earnings stood at -$329.4 million in 2022, then decreased by 15.67% to -$381.0 million in 2023, then fell by 4.13% to -$396.7 million in 2024, then decreased by 0.48% to -$398.6 million in 2025, then slipped by 0.24% to -$399.6 million in 2026.
- Business Quant data shows MBIO's Retained Earnings at -$399.6 million in Q1 2026, -$398.6 million in Q4 2025, and -$398.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -6.33 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.57 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 4.38 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 20.91 Bn |
| 10 | Mustang Bio | 3.82 Mn | 3.82 Mn | - | -400.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -400.70 Mn |
| Mar 31, 2026 | -399.60 Mn |
| Dec 31, 2025 | -398.64 Mn |
| Sep 30, 2025 | -398.11 Mn |
| Jun 30, 2025 | -397.64 Mn |
| Mar 31, 2025 | -396.90 Mn |
| Dec 31, 2024 | -396.72 Mn |
| Sep 30, 2024 | -395.77 Mn |
| Jun 30, 2024 | -394.36 Mn |
| Mar 31, 2024 | -386.20 Mn |
| Dec 31, 2023 | -380.97 Mn |
| Sep 30, 2023 | -372.40 Mn |
| Jun 30, 2023 | -362.30 Mn |
| Mar 31, 2023 | -346.06 Mn |
| Dec 31, 2022 | -329.37 Mn |
| Sep 30, 2022 | -309.70 Mn |
| Jun 30, 2022 | -290.70 Mn |
| Mar 31, 2022 | -271.60 Mn |
| Dec 31, 2021 | -251.84 Mn |
| Sep 30, 2021 | -231.80 Mn |